The Kratom Council

Latest / Regulation

Regulation

The Patchwork Test: Why Declining To Regulate Kratom Produces More Rules, Not Fewer

A dark slate slab lying flat against a plain pale background, photographed straight on from above. A large rectangular recess is cut into the centre of the slab and is completely empty, showing bare stone. Scattered across the flat border around it are small pale square tiles, each lying at a different angle, and not one of them sits inside the recess. No markings or lettering appear anywhere.

A state that sets no kratom standard does not keep things as they are. It hands the decision to every city council inside it. Washington and Illinois show what follows, and a laboratory certificate shows the way out.

Legislators are often told that the safe move on kratom is to wait. Let the science settle. Let the federal government finish. Do nothing for now.

Doing nothing is a decision, and it has a predictable result. It does not freeze the question. It moves the question down to the cities, where it gets answered many times, by many different bodies, in ways that do not agree with each other and cannot be complied with at the same time.

Two states have now run that experiment far enough to see the outcome.

Washington wrote the cure and then declined to take it

In early 2026 the Washington legislature took up House Bill 2291. It would have regulated kratom across the state, restricted sales by age, and carried a preemption clause that would have barred cities from enacting their own bans.

The bill died in committee.

Seven Washington cities have since prohibited retail sale outright. On the bill's own terms, had it passed, none of them could have. The measure written to give retailers one statewide rule is the measure whose failure produced seven local ones instead.

The cities did not even converge on a method. Ephrata used civil infractions and licence revocation. Bellingham used a gross misdemeanour carrying up to a year in jail. Arlington went back to the business licence alone. Three councils, three enforcement tools, for the same conduct.

Illinois shows what fourteen months without a standard looks like

Illinois has a Kratom Control Act that sets an age limit and no concentration standard. In the absence of a number, its municipalities have written their own, and they are not variations on a theme. They are different instruments.

A proposed ordinance in East Peoria, retrieved and read by this publication, defines kratom to include "any parts of the plant Mitragnya speciosa, whether growing or not" along with every compound made from it. The misspelling of the botanical name is in the document. That definition puts the leaf and the concentrate inside one prohibition.

Along one stretch of the Illinois River, five towns acted within five weeks on a far narrower model, setting concentration limits and leaving natural leaf on the shelf. This publication reported that cluster and noted of three of its ordinances that "All three leave possession and consumption lawful."

So in a single state, without anyone acting in bad faith, a product can be lawful to sell in one town, unlawful to sell in the next, and in a third the plant itself can be written into the prohibition. A distributor cannot build one label for that. A retailer cannot read one rule. An enforcement officer in one county is applying a different definition from the officer thirty miles away.

That is the patchwork test. If a legislature does not supply the standard, the standard does not go unwritten. It gets written repeatedly, locally, and inconsistently.

The replacement is already on the certificate

Here is what makes this solvable. The distinction every one of those councils is reaching for already exists as a laboratory measurement, and the laboratory already runs it.

A third-party certificate of analysis on a batch of product either shows the profile of a leaf, with mitragynine dominant and 7-hydroxymitragynine at trace levels, or it shows something else: elevated 7-OH, or one of the engineered derivatives the federal government has now named.

Federal regulators have written that same line in numbers. The notice of intent published on October 14 proposes control where 7-OH exceeds one milligram per gram of product, or where the mass of mitragynine divided by the mass of the controlled alkaloid falls below one hundred to one. A leaf passes those tests. A fortified tablet does not.

The agencies have also been explicit about what they are aiming at. The Justice Department said its scheduling action "is directed at deliberately manufactured and concentrated opioid products, not traditional botanical kratom." The 7-OH proposal states that it is "not intended to apply to natural kratom leaf containing only naturally occurring trace levels of 7-OH."

A city council cannot run a laboratory. It can, however, require one. That is the difference between a tool a municipality can actually wield and a prohibition it reaches for because nothing else is on the table.

What a workable state statute says

A state that wants one rule instead of fifty has a short list of things to put in it.

Adopt the federal threshold by reference. Not a number retyped into state law, which immediately begins to drift, but a reference that tracks the federal test. A certificate then means the same thing in every jurisdiction that adopts it.

Require a batch certificate of analysis from an independent laboratory. This is the provision that does the actual work. Without it a threshold is a sentence nobody measures.

Name the engineered derivatives explicitly. Mitragynine pseudoindoxyl, MGM-15 and MGM-16 are in Schedule I by name. A state list that names them does not have to be rewritten the first time a new one appears under a familiar label.

Set a clear purchase age of 18 years of age or older, or 21+ where required by applicable state law.

Preempt local prohibition. This is the item that makes the other four mean anything. A standard that any city may override is not a standard, and Washington is the case study in what happens when the preemption clause is the part that fails.

What this does not claim

None of this means kratom leaf is free of risk, and this article does not say it is. Kratom is not approved by the Food and Drug Administration for any use, and the agency maintains a warning to consumers. Contamination, adulteration and mislabelling are real problems in this market, and the federal findings about concentrated 7-OH products are serious and are the government's own.

The argument here is narrower. Whatever a legislature decides the rule should be, it is better for that rule to exist once, at the state level, measured by a test a laboratory can run, than to be invented fifty times by councils that have been handed a question nobody else would answer.

Sources

  1. The Kratom Council — Washington's preemption bill died and a seventh city banned kratom
  2. The Kratom Council — Illinois Valley ordinances reached the buyer
  3. City of East Peoria, Illinois — Ordinance No. 4871, from the city's agenda system (retrieved and read in full)
  4. Government Publishing Office — Federal Register document 2026-20943, notice of intent of October 14, 2026 (retrieved and read in full)
  5. The Kratom Council — DEA schedules three 7-OH analogs, carrying the Justice Department statement
  6. The Kratom Council — before 7-OH there was Spice, carrying the federal assurance about natural leaf
  7. The Kratom Council — the caffeine test, on regulating the molecule rather than the plant
  8. The Kratom Council — Colorado had a number already, and collected on it

← Back to all coverage

Get new reporting by email